Unknown

Dataset Information

0

Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome.

ABSTRACT:

SUBMITTER: Schoof M 

PROVIDER: S-EPMC8357758 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome.

Schoof Melanie M   Kordes Uwe U   Volk Alexander E AE   Al-Kershi Sina S   Kresbach Catena C   Schüller Ulrich U  

Acta neuropathologica 20210715 3

Similar Datasets

Unknown Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome.
| S-EPMC9817308 | biostudies-literature
Unknown Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.
| S-EPMC10673884 | biostudies-literature
Unknown Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
| S-EPMC10708940 | biostudies-literature
Unknown MYCN amplification defines an aggressive phenotype in IDH‐mutant gliomas
| S-EPMC12380010 | biostudies-literature
Unknown Li-fraumeni syndrome.
| S-EPMC3135649 | biostudies-literature
Genomics Li-Fraumeni WGS
| PRJEB13761 | ENA
Unknown Characterization of p53 p.T253I as a pathogenic mutation underlying Li-Fraumeni Syndrome.
| S-EPMC12680149 | biostudies-literature
Unknown Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.
| S-EPMC6078201 | biostudies-literature
Unknown The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient.
| S-EPMC7282642 | biostudies-literature
Unknown Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome.
| S-EPMC4940490 | biostudies-literature